Rune Stensvold

Rune Stensvold

Contact

Rune Stensvold
T. +45 32688224 @. run@ssi.dk

Research area

  • Epidemiology and clinical significance of common intestinal parasitic protists, especially Blastocystis, Dientamoeba, and Entamoeba
  • Genetic diversity, host specificity and evolutionary aspects of intestinal protists
  • Detection and identification of non-human, eukaryotic ribosomal DNA in stool samples
  • Molecular typing of parasites, e.g. in relation to outbreaks
  • Validation of state-of-the-art diagnostics

Pubmed link

https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/40031379/?sort=date&direction=descending 

Responsibilities

  • Counseling/advisory functions related to the diagnostic services supplied by the Laboratory of Parasitology
  • Development of novel/improvement of existing diagnostic services
  • Research 

Publikationer

  • Andersen LO, Karim AB, Roager HM, Vigsnæs LK, Krogfelt KA, Licht TR, Stensvold CR Associations between common intestinal parasites and bacteria in humans as revealed by qPCR. Eur J Clin Microbiol Infect Dis.2016; 35(9), 1427-1431 https://www.ncbi.nlm.nih.gov/pubmed/27230509
  • Andersen LO, Bonde I, Nielsen HB, Stensvold CR A retrospective metagenomics approach to studying Blastocystis. FEMS Microbiol Ecol.2015; 91(7), pii: fiv072. https://www.ncbi.nlm.nih.gov/pubmed/26130823
  • Verweij JJ, Stensvold CR Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections. Clin Microbiol Rev.2014; 27(2), 371-418 PubMed
  • Stensvold CR, Lebbad M, Victory EL, Verweij JJ, Tannich E, Alfellani M, Legarraga P, Clark CG Increased sampling reveals novel lineages of Entamoeba: consequences of genetic diversity and host specificity for taxonomy and molecular detection. Protist.2011; 162(3), 525-541 PubMed
  • Stensvold CR, Suresh GK, Tan KS, Thompson RC, Traub RJ, Viscogliosi E, Yoshikawa H, Clark CG Terminology for Blastocystis subtypes--a consensus. Trends Parasitol.2007; 23(3), 93-96 PubMed

Forskningsstøtte   

  • Christen Rune Stensvold har modtaget støtte til forskningsaktiviteter fra bl.a. Forskningsrådet for Sundhed og Sygdom, Lundbeck, Marie Curie Actions (EU), EUopSTART, A.P. Møller og TRYG Fonden for et samlet beløb af 4,5 mio. DKK.